TGFB1 and neoplasm: In glioblastoma multiforme (GBM), the release of TGFβ from glioblastoma stem cells was mediated by αv integrins and the targeting of αv integrin or blockade of the TGF-β receptor improved NK-cell function and improved tumour control in a murine model [128].